Immunovant OverviewImmunovant Net Income
Profitability analysis for IMVT.
Quarterly Net Income
-$147.86M
↓ 38.9% YoY
As of Mar 2026
Annual Net Income (TTM)
-$505.61M
↓ 22.17% YoY
Trailing 12 months ending Mar 2026
Average Net Income (Comparison Companies)
Net Income History
Net Income Comparison
Annual Net Income Growth Rate (%)
Loading...
Annual Net Income Growth (Absolute)
Loading...